Arecor Therapeutics (LON:AREC) Stock Price Up 2.6% – What’s Next?

Arecor Therapeutics plc (LON:AREC)’s share price rose 2.6% on Friday . The stock traded as high as GBX 78 ($0.98) and last traded at GBX 78 ($0.98). Approximately 42 shares traded hands during mid-day trading, a decline of 100% from the average daily volume of 14,401 shares. The stock had previously closed at GBX 76 ($0.96).

Arecor Therapeutics Trading Up 2.6 %

The company has a debt-to-equity ratio of 5.51, a quick ratio of 6.24 and a current ratio of 1.37. The firm has a market capitalization of £29.45 million, a price-to-earnings ratio of -278.57 and a beta of -0.18. The company has a 50 day moving average price of GBX 72.25 and a two-hundred day moving average price of GBX 100.01.

Arecor Therapeutics Company Profile

Arecor Therapeutics plc, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products.